Skip to main navigation Skip to search Skip to main content

Accessory Findings on F-18 FDG Positron Emission Tomography in Bronchogenic Carcinoma

  • Gerarda J.M. Herder
  • , Alle Welling
  • , Grischa V. De Winter
  • , Emile F.I. Comans
  • , Otto S. Hoekstra*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A 76-year-old man with proved small-cell and non-small-cell lung cancer and symptoms of a paraneoplastic syndrome, including a heliotrope rash; scaly erythematous rash over the face, neck, and upper torso; proximal muscle weakness; and creatine kinase elevation, underwent F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) as part of a work-up to detect (mediastinal) lymph nodes or distant metastases.

Original languageEnglish
Pages (from-to)58-59
Number of pages2
JournalClinical nuclear medicine
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • F-18 Fluorodeoxyglucose
  • Non-Small-Cell Lung Cancer
  • Paraneoplastic Syndrome
  • Polymyositis Dermatomyositis
  • Positron Emission Tomography

Fingerprint

Dive into the research topics of 'Accessory Findings on F-18 FDG Positron Emission Tomography in Bronchogenic Carcinoma'. Together they form a unique fingerprint.

Cite this